China Botanic Pharmaceutical Inc news

   Watch this stock
Showing stories 1 - 10 of about 10   

Articles published

CBPI 0.0100 0.0000 (0.00%)
price chart
Global and Chinese 1,4-Butanediol (BDO) Industry Report 2014-2017
As an important organic and fine chemical, 1,4-butanediol (BDO) is widely used in pharmaceutical, chemical, textile and household chemical fields.
Related articles »  
Growth of Wound Care Market (Products) Steady Across the World, Say New ...
For instance, in September 2013, NeoStem, Inc. (U.S.) received funding of $0.147 million from the National Institutes of Health (NIH), under the small business innovative research program (SBIR).
Related articles »  
Kymab Succeeds in Revoking Regeneron's European Patent
Kymab Limited, a monoclonal antibody biopharmaceutical company, announced today that the European Patent Office (EPO) has granted Kymab's request to entirely revoke European Patent EP1,360,287B1, owned by Regeneron Pharmaceuticals Inc.
Related articles »  
5 Stocks' Great Run: KiOR Inc (KIOR), China Recycling Energy Corp. (CREG ...
22nd Century Group Inc (NYSEMKT:XXII) rose 12.45% as the Company's wholly-owned subsidiary, Botanical Genetics, LLC, signed a worldwide license agreement with Anandia Laboratories Inc., a plant biotechnology company based in Vancouver, granting ...
Related articles »  
Discover Global blood plasma market analysis and forecast to 2020
China is expected to be the fastest growing blood plasma markets in Asia region. Some of the key driving ... Some of the major companies operating in the global blood plasma market are Baxter International Inc., CSL Limited, Grifols and Octapharma AG.
Related articles »  
Discover Global dental surgical equipment market outlook to 2020
Regular consumption of tobacco and unhealthy foods are the major causes of dental diseases. Some of the major dental diseases are plaque, cavities and periodontal disease.
Related articles »  
22nd Century Group Enters Cannabis Space
22nd Century Group, Inc. (NYSE MKT:XXII) announced today that the Company's wholly-owned subsidiary, Botanical Genetics, LLC, has entered into a worldwide license agreement with Anandia Laboratories Inc. (Anandia), a plant biotechnology company ...
Related articles »  
Global Cardiac Pacemakers - Trends, Estimates and Forecasts to 2018
The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database ...
Related articles »  
Wall Street Radar: Auxilium Pharmaceuticals (AUXL), 22nd Century Group (XXII ...
22nd Century Group Inc (NYSEMKT:XXII) said that is wholly-owned unit known as Botanical Genetics LLC, entered into an agreement with Anandia Laboratories that involves the acquisition of rights to an important cannabinoid production technologies.
Related articles »  
China Botanic Pharmaceutical Inc Reaffirms FY 2012 Guidance